Catheter-based delivery of cells to the heart

[1]  R. Benezra,et al.  Embryonic stem cells prevent developmental cardiac defects in mice , 2006, Nature Clinical Practice Cardiovascular Medicine.

[2]  M. Hedrick,et al.  Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes , 2006, Nature Clinical Practice Cardiovascular Medicine.

[3]  P. Burchardt,et al.  Postinfarction heart failure: surgical and trans-coronary-venous transplantation of autologous myoblasts , 2006, Nature Clinical Practice Cardiovascular Medicine.

[4]  N. Dib,et al.  Surgical and catheter delivery of autologous myoblasts in patients with congestive heart failure , 2006, Nature Clinical Practice Cardiovascular Medicine.

[5]  A. Zeiher,et al.  Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial , 2006, Nature Clinical Practice Cardiovascular Medicine.

[6]  W. Wijns,et al.  Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction , 2006, Nature Clinical Practice Cardiovascular Medicine.

[7]  Masaaki,et al.  Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI , 2006, Nature Clinical Practice Cardiovascular Medicine.

[8]  S. Gronthos,et al.  Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium , 2006, Nature Clinical Practice Cardiovascular Medicine.

[9]  D. Torella,et al.  Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration , 2006, Nature Clinical Practice Cardiovascular Medicine.

[10]  A. Terzic,et al.  Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny , 2006, Nature Clinical Practice Cardiovascular Medicine.

[11]  R. Hendel,et al.  A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. , 2005, Journal of the American College of Cardiology.

[12]  W. Wijns,et al.  Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety , 2005, Circulation.

[13]  Ping Zhang,et al.  Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery: Implications for Current Clinical Trials , 2005, Circulation.

[14]  J. Badimón,et al.  Real time magnetic resonance guided endomyocardial local delivery , 2005, Heart.

[15]  J. García-Sancho,et al.  Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction , 2004, Circulation research.

[16]  L. Benet,et al.  Novel percutaneous adventitial drug delivery system for regional vascular treatment , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[18]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[19]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. , 2004, Circulation.

[20]  M. Greeley,et al.  Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs , 2004, The Lancet.

[21]  A. Yeung,et al.  Evaluation of high‐pressure retrograde coronary venous delivery of FGF‐2 protein , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  P. Serruys,et al.  Efficacy of Percutaneous Intramyocardial Injections Using a Nonfluoroscopic 3-D Mapping Based Catheter System , 2002, Cardiovascular Drugs and Therapy.

[23]  Patrick W Serruys,et al.  Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. , 2003, Journal of the American College of Cardiology.

[24]  M. Kurpisz,et al.  Myocardial Replacement Therapy , 2003, Circulation.

[25]  Elliot R. McVeigh,et al.  Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.

[26]  A. Hagège,et al.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[27]  T. Guy,et al.  Adenovirus-catheter compatibility increases gene expression after delivery to porcine myocardium. , 2003, Human gene therapy.

[28]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[29]  W. Sherman.  - 11-Cellular Therapy for Chronic Myocardial Disease : Nonsurgical Approaches , 2003 .

[30]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[31]  Robert J Lederman,et al.  Incomplete retention after direct myocardial injection , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[32]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[33]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[34]  A. Hagège,et al.  Myoblast transplantation for heart failure , 2001, The Lancet.

[35]  J. Isner,et al.  Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia , 2000, Circulation.

[36]  J. Leiden,et al.  Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: an important determinant of the efficiency of cardiovascular gene transfer. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[38]  Doris A Taylor,et al.  Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.

[39]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[40]  R. C. Chiu,et al.  Cell Transplantation for Myocardial Repair: An Experimental Approach , 1992, Cell transplantation.